Skip to main content

To further support cell growth in natural and a physiologically relevant environment, we at are introducing a glucose-free version of Plasmax to complement the original Plasmax formulation.

This defined medium is unique in offering a glucose-free formulation that opens up possibilities for tailored experimental conditions in cancer and cell biology research. It can support a applications including glucose starvation experiments, tumour microenvironment and cancer metabolism studies, metabolic tracing of glucose incorporating stable isotopes (e.g. 13C), etc. which could shed light on critical pathways and mechanisms underlying cancer cell metabolism and glucose utilisation.

While this glucose-free PlasmaxTM eliminates glucose from its formulation, it still preserves the original optimised composition of PlasmaxTM derived from over 80 components. These constituents encompass amino acids and derivatives, inorganic salts, trace elements, and vitamins, with more than 50 components present at levels mirroring those found in human plasma. Hence, the formulation ensures cultured cells closely mimic physiological and metabolic profiles of their in vivo counterparts.

Proven to provide tailored experimental conditions in a physiologically relevant environment, glucose-free PlasmaxTM can support research projects aimed at advancing cancer research and associated metabolic studies.

About / Cancer Research UK, the research tools arm of CRUK, is a non-profit, global community of cancer researchers, academic institutes and societies, with a shared mission to accelerate cancer research. In this collaborative, researchers contribute research tools and share knowledge to deepen our understanding of cancer, and drive innovation within cancer research.
Cancer Research UK (CRUK) is the world’s leading charity dedicated to beating cancer through research. It invests more than £400 million annually into cancer research through funding schemes, conferences, initiatives, resources, and a UK-wide network of research infrastructure across basic, translational, clinical and population research.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster. uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.